ICU Medical ROA 2006-2018 | ICUI

Current and historical return on assets (ROA) values for ICU Medical (ICUI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. ICU Medical ROA for the three months ending September 30, 2018 was 12.40%.
ICU Medical ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.09B $1.55B 5.68%
2018-06-30 $0.09B $1.53B 5.70%
2018-03-31 $0.02B $1.49B 1.20%
2017-12-31 $0.07B $1.50B 4.62%
2017-09-30 $0.03B $1.52B 2.24%
2017-06-30 $0.05B $1.49B 4.41%
2017-03-31 $0.10B $1.47B 11.56%
2016-12-31 $0.06B $0.71B 9.51%
2016-09-30 $0.06B $0.69B 9.02%
2016-06-30 $0.06B $0.66B 8.83%
2016-03-31 $0.05B $0.64B 8.68%
2015-12-31 $0.05B $0.63B 7.62%
2015-09-30 $0.05B $0.61B 8.26%
2015-06-30 $0.04B $0.57B 6.75%
2015-03-31 $0.03B $0.55B 5.41%
2014-12-31 $0.03B $0.54B 4.96%
2014-09-30 $0.03B $0.53B 6.23%
2014-06-30 $0.04B $0.52B 7.42%
2014-03-31 $0.04B $0.51B 7.89%
2013-12-31 $0.04B $0.50B 8.61%
2013-09-30 $0.04B $0.47B 8.72%
2013-06-30 $0.04B $0.45B 9.24%
2013-03-31 $0.04B $0.44B 10.04%
2012-12-31 $0.04B $0.43B 10.18%
2012-09-30 $0.05B $0.41B 12.18%
2012-06-30 $0.04B $0.39B 11.94%
2012-03-31 $0.04B $0.38B 12.33%
2011-12-31 $0.04B $0.36B 12.75%
2011-09-30 $0.04B $0.34B 10.53%
2011-06-30 $0.04B $0.35B 10.89%
2011-03-31 $0.03B $0.33B 11.09%
2010-12-31 $0.03B $0.31B 10.14%
2010-09-30 $0.03B $0.30B 9.13%
2010-06-30 $0.02B $0.29B 8.05%
2010-03-31 $0.02B $0.29B 7.30%
2009-12-31 $0.03B $0.31B 8.25%
2009-09-30 $0.03B $0.31B 9.44%
2009-06-30 $0.03B $0.30B 10.47%
2009-03-31 $0.03B $0.29B 10.48%
2008-12-31 $0.03B $0.28B 9.43%
2008-09-30 $0.02B $0.27B 8.63%
2008-06-30 $0.02B $0.26B 7.62%
2008-03-31 $0.02B $0.25B 6.84%
2007-12-31 $0.02B $0.24B 9.64%
2007-09-30 $0.03B $0.25B 10.03%
2007-06-30 $0.03B $0.26B 10.55%
2007-03-31 $0.03B $0.25B 12.12%
2006-12-31 $0.03B $0.24B 10.83%
2006-09-30 $0.02B $0.24B 10.41%
2006-06-30 $0.02B $0.23B 10.95%
2006-03-31 $0.02B $0.22B 11.03%
2005-12-31 $0.02B $0.21B 10.58%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.490B $1.293B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $125.111B 19.18
Abbott Laboratories (ABT) United States $123.927B 25.11
Stryker (SYK) United States $63.616B 23.98
Boston Scientific (BSX) United States $51.104B 25.83
Baxter (BAX) United States $32.759B 21.16
Zimmer Biomet Holdings (ZBH) United States $23.343B 15.14
Smith & Nephew SNATS (SNN) United Kingdom $15.929B 0.00
ResMed (RMD) United States $14.783B 28.19
Canopy Growth (CGC) Canada $9.096B 0.00
Perrigo (PRGO) Ireland $8.909B 13.52
Bio-Rad Laboratories (BIO) United States $8.086B 51.70
Aurora Cannabis (ACB) Canada $6.688B 36.63
Hill-Rom Holdings (HRC) United States $6.277B 19.90
Haemonetics (HAE) United States $5.440B 47.85
Insulet (PODD) United States $4.849B 0.00
Hutchison China MediTech (HCM) China $4.221B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.051B 0.00
Agios Pharmaceuticals (AGIO) United States $3.732B 0.00
Neogen (NEOG) United States $3.281B 49.69
National Vision Holdings (EYE) United States $3.207B 70.82
NuVasive (NUVA) United States $2.954B 27.49
Aphria (APHA) $2.817B 0.00
Quidel (QDEL) United States $2.479B 32.31
NxStage Medical (NXTM) United States $1.925B 0.00
Phibro Animal Health (PAHC) United States $1.446B 20.47
AtriCure (ATRC) United States $1.192B 0.00
Cardiovascular Systems (CSII) United States $1.046B 1507.50
VAREX IMAGING (VREX) United States $1.018B 16.63
PetIQ (PETQ) United States $0.849B 27.76
Meridian Bioscience (VIVO) United States $0.828B 26.38
OraSure Technologies (OSUR) United States $0.826B 46.52
Surmodics (SRDX) United States $0.787B 120.33
Eagle Pharmaceuticals (EGRX) United States $0.753B 24.16
Cerus (CERS) United States $0.715B 0.00
MacroGenics (MGNX) United States $0.702B 0.00
Omeros (OMER) United States $0.628B 0.00
Owens & Minor (OMI) United States $0.575B 6.50
Lantheus Holdings (LNTH) United States $0.572B 17.69
Insys Therapeutics (INSY) United States $0.548B 0.00
LeMaitre Vascular (LMAT) United States $0.526B 25.81
NanoString Technologies (NSTG) United States $0.455B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.401B 0.00
Quanterix (QTRX) United States $0.362B 0.00
Utah Medical Products (UTMD) United States $0.325B 20.99
Cytosorbents (CTSO) United States $0.306B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.266B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
BioLife Solutions (BLFS) United States $0.214B 289.75
Bovie Medical (BVX) United States $0.204B 0.00
Rockwell Medical (RMTI) United States $0.201B 0.00
Chimerix (CMRX) United States $0.162B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.156B 0.00
Fonar (FONR) United States $0.141B 7.11
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.091B 0.00
United-Guardian (UG) United States $0.079B 16.60
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.67
InfuSystems Holdings (INFU) United States $0.060B 0.00
CAS Medical Systems (CASM) United States $0.055B 0.00
Neurotrope (NTRP) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
Valeritas Holdings (VLRX) United States $0.025B 0.00
Myomo (MYO) United States $0.024B 0.00
Senestech (SNES) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00